Showing 221-230 of 2792 results for "".
Two Cases of Nephrotic Syndrome Presenting as Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/two-cases-of-nephrotic-syndrome-presenting-as-ischemic-stroke/30313/Nephrotic syndrome may be more common than previously realized as a cause of hypercoagulability in ischemic stroke of unclear etiology.Fresh Approaches to MS Care
https://practicalneurology.com/columns/practice-management/fresh-approaches-to-ms-care/30712/New treatment options encourage a fresh approach to patients.Biomarkers Setting the Pace of Alzheimer's Research
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/biomarkers-setting-the-pace-of-alzheimers-research/30609/Clinicians and researchers must determine how to best use emerging data, such as information on biomarkers.In Epilepsy Care, Non-pharmacologic Research Takes Center Stage
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-epilepsy-care-non-pharmacologic-research-takes-center-stage/30602/Researchers say minimally invasive surgeries, alternative interventions, and new genetic findings are the top stories of 2014.Special Report: AAN Annual Meeting: Video Coverage, Study Highlights, and More
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/special-report-aan-annual-meeting-video-coverage-study-highlights-and-more/30458/Novel Ideas Dot Future of Headache Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/novel-ideas-dot-future-of-headache-care/30617/Two specialists share their thoughts on the year that was in headache care, as well as three novel delivery systems to look for in the future.Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.The Fragile X-Associated Tremor/Ataxia Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/PN0809_08-php/30899/Relatively recently described, FXTAS is a progressive genetic disorder for which there is no cure, but symptomatic therapy is indicated.Managing Symptoms of Anxiety, Panic, Depression, Apathy, and Pseudobulbar Effect in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/managing-symptoms-of-anxiety-panic-depression-apathy-and-pseudobulbar-effect-in-individuals-with-parkinson-disease/37655/Neuropsychiatric symptoms associated with Parkinson disease, including anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment as well as consideration of various treatment options to improve quality of life in this population.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.